Raymond James Financial
AHCO icon

Raymond James Financial’s AdaptHealth AHCO Stock Holding History

Raymond James Financial’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$175K Sell
14,669
-53
-0.4% -$542 ﹤0.01% 4915
2025
Q4 		$147K Sell
14,722
-5,174
-26% -$49.4K ﹤0.01% 4857
2025
Q3 		$178K Sell
19,896
-93,861
-83% -$869K ﹤0.01% 4655
2025
Q2 		$1.07M Sell
113,757
-26
-0% -$229 ﹤0.01% 3534
2025
Q1 		$1.23M Buy
113,783
+93,082
+450% +$937K ﹤0.01% 3332
2024
Q4 		$197K Buy
+20,701
New +$210K ﹤0.01% 4409

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Raymond James Financial's AHCO Position: Q1 2026 in Review

Raymond James Financial reduced its AdaptHealth (AHCO) stake by 0.36% in Q1 2026, selling an estimated $542 and leaving 14,669 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #4915.

Raymond James Financial first reported a position in AHCO in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.23M in Q1 2025. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Raymond James Financial held 14,669 shares of AdaptHealth worth $175K as of Q1 2026.
  • Raymond James Financial sold 53 AdaptHealth shares in Q1 2026, an estimated $542.
  • AdaptHealth made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4915 holding.
  • Raymond James Financial first reported a position in AdaptHealth in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's AdaptHealth position peaked at $1.23M in Q1 2025.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.